Gebre Teklemariam Demoz

Gebre Teklemariam Demoz

Pharmacy, Aksum University, Āksum, Tigray, Ethiopia
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2019 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
Gebre Teklemariam DemozGebre Teklemariam Demoz
Gebre Teklemariam Demoz
AGAlem Gebremariam
Alem Gebremariam
HBHelen Yifter Bitew
Helen Yifter Bitew
MAMinyahil Alebachew
Minyahil Alebachew
YNYirga Legesse Niriayo
Yirga Legesse Niriayo
WSWorkineh Shibeshi
Workineh Shibeshi
Contemporary clinical guidelines endorsed that glycemic control is the ultimate goal in the management patients with diabetes. The aim of this study was to assess the prevalence of glycemic control and to identify predictors of poor glycemic control in patients with type 2 diabetes (T2D). A cross-sectional study was conducted among systematically selected 357 diabetic patients. Data were collected through direct patients’ interviews and medical chart review. Binary logistic regression analyses were performed and analyzed using SPSS version 22.0. Participants’ mean age was (± SD) 56.1 ± 11.6 years. Nearly four in five (77.9%) of the participants had comorbidities, mainly of hypertension, and 60.2% had diabetic complications, mainly diabetes neuropathy. Poor glycemic control was found in 68.3% of the participants with a mean (± SD) FBG of 174.1 ± 48.9 mg/dL. Being female gender, having greater body mass index and low medication adherence was significantly associated with poor glycemic control. In conclusion, the overall aspects of glycemic control level of patients were far from the standards. Being female, greater body mass index and poor medication adherence were predictors of poor glycemic control. In response to this finding, an aggressive intervention that targets in improving the glycemic control is required.

9 July 2019 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
Gebre Teklemariam DemozGebre Teklemariam Demoz
Gebre Teklemariam Demoz
SWShishay Wahdey
Shishay Wahdey
GKGebremicheal Gebreslassie Kasahun
Gebremicheal Gebreslassie Kasahun
KHKalay Hagazy
Kalay Hagazy
DKDaniel Gebrehawaria Kinfe
Daniel Gebrehawaria Kinfe
YNYirga Legesse Niriayo
Yirga Legesse Niriayo
Although most clinical practice guidelines endorsed statin use in type 2 diabetes (T2D) patients for reducing cardiovascular diseases (CVD), little is known about statin utilization in case of Ethiopia. Hence, this study was aimed to evaluate prescribing pattern of statins for primary prevention of CVD in T2D patients. A retrospective study conducted in T2D patients with the age group of 40–75 years. Prescriptions were audited for details of statin use and dose intensity. Descriptive analysis was performed using SPSS version 22.0. We included a total of 323 study subjects. Of those, 55.7% study subjects were found to be received statin for their primary prevention of CVD. Commonly prescribed type of statins was simvastatin (37.2%), atorvastatin (32.8%) and rosuvastatin (15.6%). Low, moderate and high intensive dose of statins were prescribed in 27.8%, 46.1%, and 26.1%, respectively. Of those subjects received statin, 60.6% had on target cholesterol level. Overall, a significant percentage of subjects did not receive their recommended statin for primary prevention of CVD which is below the guidelines’ recommendation. Therefore, adherence to guidelines may help to promote the use of statins for primary prevention of CVD in T2D and advance interventions to improve statin prescribing should be considered.

1 October 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Gebre Teklemariam DemozGebre Teklemariam Demoz
Gebre Teklemariam Demoz
ABAlemseged Beyene Berha
Alemseged Beyene Berha
MWMinyahil Alebachew Woldu
Minyahil Alebachew Woldu
HBHelen Yifter Bitew
Helen Yifter Bitew
WSWorkineh Shibeshi
Workineh Shibeshi
EEEphrem Engidawork
Ephrem Engidawork
Patients with diabetes are at high risk of drug therapy problems (DTPs), as they are receiving multiple medications. To date, studies regarding DTPs in patients with diabetes in Ethiopia are limited. The aim of this study was to assess prevalence of DTPs, medication adherence and treatment satisfaction of patients with diabetes at Tikur Anbessa Specialized Hospital (TASH). A cross-sectional study was conducted on randomly selected 418 participants who fulfilled the inclusion criteria. Data were collected using structured questionnaire and patients’ chart review. Cipolle’s classification system was used to determine DTPs. Modified Morisky’s Adherence Scale (MMAS-8) was used to measure patients’ adherence to their medication. Treatment Satisfaction with Medicines Questionnaire (SATMED-Q) patient satisfaction assessment questionnaire was used to assess patients’ treatment satisfaction. A total of 207 DTPs in 177 (42.3%) of participants were identified. Commonly identified DTPs were dosage too low (58, 28.0%), ineffective drug therapy (54, 26.1%), and need additional drug therapy (52, 25.1%). Factors associated with DTPs were female gender (Adjusted Odds Ratio [AOR] = 2.31,95% CI:1.30–4.12); ≥3comorbidities (AOR = 3.61, 95% CI:1.19–10.96); ever married (AOR = 2.58,95% CI:1.23–5.48); type 2 diabetes (AOR = 5.62, 95% CI:1.21–26.04); non-adherence (AOR = 5.26,95% CI:2.51–11.04) and residence out of Addis Ababa (AOR = 0.30, 95% CI:0.12–0.73). Twenty four percent of participants were non-adherent to their drug therapies. Factors associated with non-adherence were diabetes complications (AOR = 2.00, 95% CI: 1.2–3.32), the female gender (AOR = 1.67, 95%CI: 1.01–2.8) and level of education (AOR = 0.42, 95%CI: 0.18–0.96). Eighty one percent of participants were satisfied with the current treatment. A significant proportion of patients were satisfied with their treatment and a quarter of the study participants were non-adherent to their medications at TASH diabetic clinic. However, DTPs were considerably higher among the study participants. Hence, future interventions targeting prevention and resolution of DTPs deemed to be necessary.

16 July 2020 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
Gebre Teklemariam DemozGebre Teklemariam Demoz
Gebre Teklemariam Demoz
SWShishay Wahdey
Shishay Wahdey
DBDegena Bahrey
Degena Bahrey
HKHalefom Kahsay
Halefom Kahsay
GWGebremariam Woldu
Gebremariam Woldu
ACAndrew Collier
Andrew Collier
Background: Poor adherence to the medical regimen is a major clinical problem in the management of patients with diabetes. This study sought to investigate the level of medication adherence to antidiabetic therapy and to identify possible predictors of poor adherence. Methods: A hospital based cross-sectional study was conducted from July 2018 to June 2019 among randomly selected follow-up T2D patients at a hospital diabetes clinic. Data were collected through patient interviews, followed by medical chart review. Adherence to antidiabetic therapy that we assessed patients’ responses using validated Brief Medication Questionnaire (BMQ). To identify predictors of poor medication adherence, binary logistic regression analyses were performed using SPSS version 25. Statistical significance was set at p value ≤ 0.05. Results: Of the total 357 study participants, 25% were non-adherent to their antidiabetic therapy. Predictors statistically associated with poor adherence were; being female gender (AOR = 1.71, 95% CI 1.01–2.76), and presence of at least one diabetic complication (AOR = 2.02, 95% CI 1.02–3.22). Participants with having at least primary level of education were more likely to adhere to anti-diabetes medication (AOR = 0.42, 95% CI 0.18–0.96). The most common self-reported reasons for non-adherence were forgetfulness, unavailability of medication plus the unaffordability of anti-diabetes medications. Conclusions: The proportion of participants’ adherent to anti-diabetes therapies was suboptimal. Being female, the presence of chronic diabetic complications and having no formal education were the main predictors of poor adherence. Strategies that aimed at improving adherence to antidiabetic medications deemed to be compulsory.

1 August 2020 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
Gebre Teklemariam DemozGebre Teklemariam Demoz
Gebre Teklemariam Demoz
GKGebremicheal Gebreslassie Kasahun
Gebremicheal Gebreslassie Kasahun
KHKalay Hagazy
Kalay Hagazy
GWGebremariam Woldu
Gebremariam Woldu
SWShishay Wahdey
Shishay Wahdey
YNYirga Legesse Niriayo
Yirga Legesse Niriayo
Background: Irrational prescribing of antibiotics is a universal public health problem, leading to antibiotic resistance. Understanding the prescribing pattern of antibiotics is crucial to tackling irrational prescription. Yet, comprehensive studies regarding the prescribing pattern of antibiotics among inpatients and the need for an Antibiotic Stewardship Program (ASP) are lacking in Ethiopia. This study aimed to evaluate prescribing patterns of antibiotics and the need for an ASP. Methods: A hospital-based prospective observational study was carried out from February 2019 to December 2019. This study was conducted among patients admitted to Aksum University Comprehensive Specialized Hospital, Ethiopia. Data were collected using a data abstraction format generated by World Health Organization (WHO) prescribing indicators. Data analysis was carried out using SPSS version 25.0. Results: A total of 1653 antibiotics were prescribed for 822 inpatients. Overall, 52.3% of patients had at least one oral and/or injectable antibiotic prescribed, for a mean duration of 4.2 (SD=2.3) days. The average number of prescribed antibiotics per patient was 2.01 (SD=1.9). The majority (97.6%) of antibiotics were prescribed by their generic name, and all prescribed antibiotics were from the national Essential Medicine List (EML). Frequently prescribed injectable and oral antibiotics were ceftriaxone (24.5%) and azithromycin (12.9%), respectively. Culture and sensitivity testing were not performed in any of the cases. During the study period, 65.2% of key antibiotics were available in stock. Conclusion: In this study, more than half of patients were on at least one antibiotic, and all antibiotics were prescribed from the national EML. However, all antibiotics were prescribed empirically. This result shows that the prescribing pattern of antibiotics in the hospital deviates from and is non-compliant with the standard endorsed by WHO. This study provides evidence for the necessity and a way forward for the establishment of an ASP in the hospital that may help to introduce the prescribing of antibiotics with the aid of culture and sensitivity tests, and to develop institutional guidelines.

Gebre Teklemariam DemozGebre Teklemariam Demoz
Gebre Teklemariam Demoz
YNYirga Legesse Niriayo
Yirga Legesse Niriayo
Abraha HailuAbraha Hailu
Abraha Hailu
LMLilian Mbau
Lilian Mbau
Manuel Cruz Gonzalez GarciaManuel Cruz Gonzalez Garcia
Manuel Cruz Gonzalez Garcia
Cardiac rehabilitation (CR) reduces mortality and hospitalisation after cardiovascular events, yet it is available in only 17% of African countries. Mobile health (mHealth) can extend CR beyond the hospital, and the 2026 ESC Guidelines now recognise digitally supported telerehabilitation as a delivery option. How global mHealth CR models could be adopted or adapted within African health systems remains unclear. This scoping review will map global evidence on the implementation and uptake of mHealth-supported remote CR and examine its implications for Africa. Following the Joanna Briggs Institute methodology and the Population–Concept–Context framework, we will search PubMed, Scopus, EMBASE and Web of Science for English-language studies published from 2016 to June 2026, complemented by an Africa-focused search that includes grey literature. Adults with any guideline-recommended indication for CR will be eligible. Two reviewers will independently screen studies and chart data on delivery models, technologies, CR components, implementation outcomes, barriers and facilitators. Findings will be synthesised descriptively and thematically, guided by established implementation frameworks, interpreted against African health-system factors, and reported according to PRISMA-ScR. The review will identify potentially transferable models, necessary adaptations and evidence gaps to guide research, policy and equitable implementation of digital CR in Africa. The protocol is registered on the Open Science Framework.